what does the glp 1 receptor do GLP-1 agonists for individualized treatment of type 2 diabetes mellitus Glucagon Like Peptide 1 Receptor

Rise of Dual and Triple Agonists: Beyond GLP-1, newer drugs target GIP and glucagon receptors for enhanced efficacy (e.g., Tirzepatide, Retatrutide)

Across the RCTs, CoQ10 dropped: Systolic BP by 16.6 mm Hg Diastolic BP by 8.2 mm Hg (both with no change in the placebo group) In the crossover study, CoQ10 dropped: Systolic BP by 11 mm Hg Diastolic BP by 8 mm Hg Even in open-label studies (less controlled), CoQ10 dropped: Systolic BP by 13.5 mm Hg Diastolic BP by 10.3 mm Hg These numbers are on par with most commonly prescribed antihypertensive (blood pressure) drugs

J Am Coll Cardiol 2024;84:27-40.PubMed 96

Consumers who have stopped using the drug are now looking for ways to sustain their weight loss, adopting GLP-1 inspired eating patterns focused on portion control, fiber, and high protein intake